Bracco Imaging Announces New Agreement with Sonothera™
Thursday, April 13, 2023
Bracco Imaging and SonoThera have entered into an agreement under which Bracco Imaging will provide its cutting-edge gas-filled microbubbles technology platform to SonoThera for use in the development of its novel, ultrasound-guided nonviral gene therapy platform.
The combination of ultrasound energy with microbubble allows transient permeability of vessel walls and cell membranes to enable the delivery of therapeutic nucleic acid payloads. The agreement will allow SonoThera to fully explore the potential of this innovative approach to facilitate the safe and effective delivery of various genetic materials to target cells/organs with minimal off-target delivery.
As part of this new agreement, Bracco Imaging will grant SonoThera a non-exclusive licence to use Bracco's microbubble for Research purposes.
The combination of Bracco's innovative gas microbubbles platform with SonoThera's ongoing development of a nonviral gene delivery platform will undoubtedly advance development in this novel approach to gene therapy.
